Skip to NavigationSkip to content

New UK headquarters for Bristol-Myers Squibb

Published on 05/12/05 at 12:58pm

Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.

The £5.5 million building houses over 200 employees, and BMS says the offices symbolise its commitment to working and investing in the UK.

In a special message, delivered for the occasion, Jane Kennedy minister of state for health, said: "The pharmaceutical industry creates huge benefits in both treating patients, and bringing investment into the UK. Bristol-Myers Squibb's £5.5 million investment in Uxbridge demonstrates its continued commitment to the UK."

She also reconfirmed the government's determination to maintain the UK as a good business environment for the industry and indicated that BMS research into cancer, diabetes and obesity was in line with the government's own priorities in health.

BMS is the sixth largest supplier of hospital products to NHS hospitals, and has launched three major new products in the UK over the last two years in the areas of schizophrenia, HIV and analgesia.  

David Veitch, European vice-president and general manager of Bristol-Myers Squibb UK, said: "Bristol-Myers Squibb is a pharmaceutical company that is looking confidently to the future; the modern, open and innovative design of our new head office reflects this confidence."

The company's late-stage pipeline includes a promising new first-in-class treatment for rheumatoid arthritis, Orenica (abatacept).

The drug is set to gain final FDA approval in early 2006. But the future of another late-stage drug, muraglitizar, looks gloomy, with BMS and partner Merck now considering abandoning its development following FDA requests for significantly more safety data.




Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches